SCHEMBL19106360

SCHEMBL19106360

c1ccc(-c2cc(-c3cc(-c4ccc5c(ccc6ccccc65)c4)cc(-c4nc(-c5ccccc5)c5sc6ccccc6c5n4)c3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.36
▸ KMT2A Q03164 7/20 0.36
▸ MAPT P10636 6/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ HPGD P15428 4/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ CYP1A1 P04798 3/20 0.34
▸ CYP1B1 Q16678 3/20 0.34
▸ LIMK1 P53667 2/20 0.34
▸ LMNA P02545 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ TNKS O95271 2/20 0.32
▸ TNKS2 Q9H2K2 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ RECQL P46063 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106366 0.99 CYP1A1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106354 0.95 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1CYP1A1
SCHEMBL19106377 0.94 LIMK1 (0.39) MEN1KMT2AMAPTCYP1A1CYP1B1
SCHEMBL19106376 0.93 LIMK1 (0.38) MEN1KMT2AMAPTCYP1A1CYP1B1
SCHEMBL19106358 0.90 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106348 0.90 CYP1A1 (0.37) MEN1KMT2AMAPTCYP1A1CYP1B1
SCHEMBL19106219 0.89 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106363 0.89 LIMK1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106359 0.89 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106356 0.89 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885MAPT 455/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885MAPT 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback